Worst-of Autocallable Note for a Conservative Client
You are a compliance reviewer at a retail brokerage. A relationship manager has recommended a 5-year worst-of autocallable note to a 68-year-old retired client with HKD 3 million in liquid savings and an annual income need of HKD 120,000. The client has low risk tolerance, no derivatives experience, and wants to preserve capital. The note requires a HKD 1 million investment. It pays 2.0% quarterly (8% per annum) if both underlying technology stocks are at or above 70% of their initial levels on each observation date. It autocalls quarterly if both are at or above 100%. If not called and either stock finishes below 70%, the client receives the worst-performing stock, with 1:1 downside below that level; otherwise principal is returned. The issuer is an A-rated bank. There is no secondary market. The RM's file says '8% coupon with a 70% buffer; likely called in year one.' The client asks whether the coupon is guaranteed and what happens if one stock falls 45%.
1. Explain the note's payoff and identify the main risks for this client.
Read the worked answer
The note pays 2.0% quarterly only if both stocks are at or above 70% of initial on each observation date. If both are at or above 100%, it autocalls and returns principal plus accrued coupon. If not called and either stock finishes below 70%, the client receives the worst-performing stock, with 1:1 downside below that level; if the worst stock falls 45%, the client would receive shares worth about 55% of principal, a loss of about HKD 450,000 on HKD 1 million, plus lost coupons. If the stocks stay between 70% and 100% and the note is not called, principal is returned but coupons may be missed. Main risks are equity downside, worst-of correlation, autocall and reinvestment risk, issuer credit risk, liquidity risk because there is no secondary market, and complexity or misunderstanding. The 8% coupon is not guaranteed; it is compensation for selling downside protection and accepting lock-up. The 70% buffer is not a stop-loss; it is a threshold for principal loss.
2. Assess suitability and the RM's conduct against the client's profile.
Read the worked answer
The recommendation is likely unsuitable. The client is 68, needs HKD 120,000 annual income, has low risk tolerance and wants capital preservation. A HKD 1 million allocation is one-third of liquid savings and is locked for up to five years with no secondary market. The note can lose a large part of principal if either technology stock falls below 70%, and the worst-of feature means one bad stock drives the outcome. The client has no derivatives experience. The RM's statement that it is 'likely called in year one' is a forecast, not a safeguard, and may create a misleading impression. The 8% coupon may tempt a yield-seeking retiree, but it is not guaranteed and the income need could be met with lower-risk assets. The RM should have considered a diversified bond ladder, short-duration deposits, or a principal-protected product. If the RM used urgency or emphasized the buffer without explaining the worst-of downside, that is a suitability and sales-conduct breach.
3. If the client still insists after a proper explanation, what should the firm do?
Read the worked answer
The firm should document the client's profile, the suitability assessment, the specific risks explained, and the client's written acknowledgement that the product is not principal-protected and may be illiquid. It should reduce the allocation to a level the client can afford to lose, consider a smaller ticket, and confirm the client has separate emergency funds and income. The firm should not accept an instruction that is clearly unsuitable without an escalated approval and a second review. It should provide scenario examples, including a 45% fall in one stock, missed coupons and no autocall. The RM's compensation should not create a conflict; disclose any commission. If the client is still insistent, the firm may decline to transact or require a senior manager sign-off. Post-sale, monitor concentration and provide statements. The key is that informed consent does not cure a product that the firm knows is unsuitable for the client's stated needs.